IPIRA Impact

Faster, More, Better, Creative

Deals that make sense, don't get us in trouble, and uphold our mission and principles

"Preferred partner" —Dow
"One of five best" —Inc. Magazine
"Breakthrough business model" —National Academy of Sciences Institute of Medicine
Deal of Distinction —Licensing Executives Society
Patents for Humanity award —US Patent and Trademark Office
Legacy Award 2016 —East Bay Economic Development
Highest Number of Startups Formed Among Universities — Pitchbook
Second Highest Number of Entrepreneurs — PitchBook

$1B+

in Funds raised

including more than $1 Billion in Industry Sponsored Research and over $250M in Licensing Revenue.

730+

Products commercialized

from discoveries licensed through IPIRA such as of treatment for malaria and cancer, biofuels, robotic legs, DNA sequencing, surgical tools, forensic tools, handheld diagnostics, gene editing, mobile microscopy, nanowires, RFID, internet security software, search engines and more.

273

Startups founded

to commercialize inventions and copyrights under licenses from IPIRA, attracting $1.6B in venture funding and $51M in SBIR/STTR grants since 2005. 44 Startups have had a successful exit via merger or acquisition, totaling $8.1B in cash and stock options, plus 24 startups have exited through an IPO. 66 Berkeley startups currently in the Bay Area employ 1,543 Californians & generate $195M in annual revenue.

1300+

Companies served

through negotiated agreements with IPIRA, including $500M in industry sponsored research from British Petroleum for the Energy Biosciences Institute, >$5M in industry sponsored research from Aduro, and $89M in licensing revenue from Bristol-Myers Squibb.

6

Industry Sponsored Institutes developed

including the C3.ai Digital Transformation Institute, Energy Biosciences Institute, California Research Alliance, Laboratory for Genomics Research, Functional Genomics Laboratory, and the Immunotherapeutics and Vaccine Research Initiative

gender and age, CEO gender and age, diversity, gender and age, CEO gender and age, diversity, gender and age, CEO gender and age, diversity

News about companies born out of licensing UC Berkeley intellectual property rights

3/21/23

Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company

2/10/23

ProterixBio Announces Commercial Offering of Quantitative Soluble ST2 Assay

12/20/22

Harnessing the Potential of Regenerative Stem Cell Secretomes in Age-related Disease

11/12/22

Intellia Talks 'Functional Cure' for HAE with Interim Data for 2nd CRISPR Candidate

11/8/22

Juvena Therapeutics Secures $41 Million to Accelerate the Discovery and Development of Biologics for Chronic and Age-Related Diseases

11/1/22

Pittsburgh Knights Partners with Setex for eGame Thumbgrips with Gecko-inspired Anti-slip Technology

10/27/22

DOE Funds Travertine to Grow the Minerals Supply Chain and Strengthen National Security

10/19/22

Ambi Robotics Raises Funding for New Kind of Warehouse Robot

10/5/22

Valitor Raises $28M Series B Financing

10/5/22

Former Berkeley Professor and Startup Founder Carolyn Bertozzi Shares Chemistry Nobel Prize

9/29/22

GM Partners with and Invests in OneD Battery Sciences in Quest for Cheap, Energy-dense EV Batteries

9/27/22

Sanofi and Jennifer Doudna-Founded Scribe Ink $1B CRISPR Cell Therapy Deal

9/14/22

Cultured meat startup Prolific Machines unveils its ‘Henry Ford approach’ to cell growth

9/4/22

Intropic Materials Selected as Biomimicry Ray of Hope Prize Finalist

8/23/22

Clarity Movement Co. Raises US$9.6M Series A+

8/17/22

Vicinitas Therapeutics Launches With $65 Million in Series A Financing to Advance Precision Medicines to Stabilize Key Proteins to Treat Disease

8/4/22

Discovery, Functional Characterization, and Recovery of a Patient-Derived T cell Receptor Sequence Against a Cancer Neoantigen

7/29/22

Synthetic Bio Startup Huue Secures $14.6M Series A to Launch The World’s First Clean & Scalable Indigo Dye

7/25/22

Quantum Dot and MicroLED Pioneer Nanosys Secures Over $50 Million in Growth Capital Financing

7/15/22

The Secret Behind the Bay Area’s Most Popular Tropical Beers: GMO Yeast

7/15/22

Your Choice Raises $15M in Series A

7/1/22

Serinus Labs Recognized Among World's Top 15 Techpreneurs

6/23/22

Magnetic Insight Raises $17M in Series B

6/16/22

Travertine Raises $3M to Commercialize Carbon Capture Technology

6/9/22

ResVita Bio Receives Rare Pediatric Disease Designation for RVB-001 as a Treatment for Netherton Syndrome

5/23/22

From DNA to RNA to KaRNAteq

5/12/22

Caribou Aces its First Round of Human Data in Search of an Off-the-shelf CAR-T Breakthrough

5/10/22

Startup to Sale: How Tom McDonald Built and Sustained Mosaic Materials

5/3/22

Nanosys Quantum Dot Technology Wins Display Component of The Year Award

5/2/22

Scribe Therapeutics Expands Collaboration With Biogen to Second Target

4/27/22

CalWave and Launch Alaska Sign MOU to Advance Wave Energy Projects

4/22/22

Baker Hughes acquires Mosaic Materials

4/18/22

Lygos and Flexible Solutions International Announce Merger to Form Leading Sustainable Specialty Ingredient Company

4/11/22

Ansa Biotechnologies Closes $68M Series A Financing

4/5/22

Demetrix and Evonik Sign Supply Agreement for Cannabinoids

3/22/22

Spotlight Therapeutics Raises $36.5 Million Series B to Advance a Pipeline of Cell-Targeted In Vivo CRISPR Gene Editing Biologics

2/28/22

Intellia Therapeutics Shows Improved, Sustained Effect from In Vivo CRISPR Treatment

2/24/22

Enable Biosciences Clinical Reference Lab Accredited by the College of American Pathologists

2/16/22

Get Me (DNA) Rewrite: Intellia’s First Acquisition Expands CRISPR Toolkit

2/9/22

BioMADE Funds Pilot Project to De-risk Toxic Product Production in US Bioindustrial Manufacturing

2/3/22

Intellia Therapeutics Announces Acquisition of Rewrite Therapeutics

2/2/22

Juvena Therapeutics Awarded CIRM Grant to Advance Myotonic Dystrophy Type 1 Therapeutic

1/25/22

DOE Awards CalWave $7.5 Million for Cutting-Edge Wave Energy Converter

1/24/22

Mammoth Biosciences Receives FDA Emergency Use Authorization for First CRISPR-based High-Throughput COVID-19 Test

1/22/22

Sugarlogix Announces Relaunch as NAMUH

1/13/22

Imprint Energy Launches New Generation of Ultrathin, Flexible, Printed Batteries

1/12/22

Intellia Adds Cardiomyopathy Patients to Existing Early-stage ATTR Study

1/10/22

6 Beer Industry Trends to Watch in 2022

1/10/22

Mercator MedSystems Receives NIH Grant for Research and Development of Local Anti-inflammatory Deep Vein Thrombosis Therapy

1/10/22

FDA Fast Track Designation Granted to 4D Molecular Therapeutics 4D-125 for the Treatment of X-linked Retinitis Pigmentosa

1/10/22

Microgrid Labs, Provider of Electrification and Microgrid Software, Raises $2.25M

1/10/22

Bayer to Pay CRISPR-focused Mammoth Biosciences $40 Million for Gene Editing Research

1/3/22

Amyris and ImmunityBio Complete Joint Venture for Next Generation COVID-19 RNA Vaccine

12/21/21

Microgrid Labs Nominated for 2022 Edison Awards

12/16/21

Nodexus Inc. Emerges from Stealth with $30 Million Series A Funding

12/14/21

Catalyze Invests In and Partners With Microgrid Labs

11/29/21

Lucira's at Home Molecular Tests Can Detect Omicron SARS CoV-2 Variant of Concern

11/24/21

Water Harvesting Technology in Smithsonian FUTURES exhibit

11/23/21

Jacobs Enters into Strategic Partnership with Microgrid Labs

11/22/21

Intellia Therapeutics Expands Phase 1 Study to Include Adults with Transthyretin Amyloidosis with Cardiomyopathy

11/11/21

First Magnetic Particle Imaging (MPI) Scanner Installed in Europe, at Stockholm Karolinska Institutet

11/8/21

Amyris Announces Joint Venture Partnership With ImmunityBio For Next Generation COVID-19 RNA Vaccine

11/4/21

Scribe Therapeutics Wins 2021 Pantheon Rising Star Award

11/2/21

Ottobock Acquires Exoskeleton Specialist suitX

10/14/21

OneD to Build Pilot Silicon-Graphite-Anode Plant

10/13/21

Intellia Therapeutics Collaborates with SparingVision to Develop Ocular Therapies

10/12/21

Lucira Health COVID-19 Test Approved for Sale in Singapore

10/7/21

Self-Destructing Plastic Wins Top Prize in Create the Future Contest

10/6/21

Intellia Phase 1/2 Clinical Trial Authorized for Hereditary Angioedema Treatment

10/6/21

CalWave Commissions Open-water Wave Energy Pilot

10/5/21

Amyris Partners with Inscripta to Enhance Development of Sustainable Ingredients

9/28/21

Acrigen Biosciences Raises Seed Financing to Advance Precision Gene Editing Technology and Therapeutic Pipeline

9/23/21

GenEdit Closes $26 Million in Series A Financing

9/21/21

Organos Awarded $1.5M NIH SBIR Grant

9/14/21

Ambi Robotics Announces $26 Million Series A Funding Led By Tiger Global

9/9/21

Research Shows Racial and Ethnic Disparities in Bay Area Air Pollution

9/9/21

Mammoth Biosciences Raises $195 Million, Vaulting Its Crispr Tech to Unicorn Status

9/8/21

Contest Challenges Inventors to Harness Wave Power to Desalinate Seawater

9/8/21

Breakthrough "Air Stable" Quantum Dot Component Enters Mass Production

8/27/21

14 Best Berkeley Medical Device Startups Revolutionizing Healthcare

8/19/21

Huue and Ginkgo Bioworks Partner to Accelerate Production of Sustainable Dyes

8/13/21

U.S. Airforce Tests SuitX Exoskeletons to Prevent Fatigue-related Accidents

8/12/21

Iaterion, Inc. Awarded NIH Grant for Nuclear Receptor Coligand Platform

8/12/21

AngioDynamics Receives FDA Approval for PRESERVE Study

8/11/21

Magnetic Insight Installs Localized Magnetic Theranostic System at Johns Hopkins University

8/11/21

FDA-approved Trial Evaluates AngioDynamics’ NanoKnife for Prostate Tissue Ablation

7/30/21

Tenaya Therapeutics Prices $180M IPO for Targeted Therapies

7/28/21

Study Reveals Gene Involved in Stem Rust Resistance in Wheat

7/26/21

StreetLight Data Partnership Aims to Help Expand EV Chargers

7/23/21

Caribou Raises $304M in One of Gene Editing's Most Lucrative IPOs

7/21/21

Berkeley startup aims to be a game changer in autoimmune disease therapy

7/19/21

With Focus on the 'Undruggable,' Biotech Raises $88.5M Series B from IPO-minded Investors

7/19/21

Frontier Medicines Raises $88.5 Million Series B Financing to Advance Precision Oncology and Targeted Protein Degradation Pipeline

7/14/21

Enable Biosciences Supports California Department of Public Health's CalScope Program to Survey COVID-19 Antibodies from Infection and Vaccination

7/13/21

Tenaya Therapeutics Preclinical Research Supports Product Candidate for Heart Disease Indications

7/12/21

Clinical Trial of CRISPR-Edited Cell Therapy Launched for Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

7/9/21

Heart disease biotech Tenaya Therapeutics files for a $100 million IPO

7/3/21

Cannabinoids Are the Next Big Thing in the Pot Industry, But Who Can Mass-Produce It?

7/2/21

Caribou Biosciences Files for $100M IPO

7/1/21

Amyris Completes First Major License For RNA COVID Vaccine Advancing Technology To Human Trials

6/29/21

Enable Biosciences Supports California Department of Public Health CalScope Program to Survey COVID-19 Antibodies from Infection and Vaccination

6/28/21

In Major CRISPR Milestone, Intellia Successfully Edits Genes Inside the Body

6/10/21

A World First in Imaging Technology, Developed by Magnetic Insight

5/20/21

Nanosys Acquires Leading MicroLED Company glō

5/20/21

Tenaya Therapeutics Receives Orphan Drug Designation for Genetic Hypertrophic Cardiomyopathy Gene Therapy

5/19/21

Inkspace Imaging Named as Finalist in Prestigious Pediatric Medical Device Competition

5/12/21

Berkeley Lights to Launch Subscription Option for Smaller Biotech Firms

5/11/21

Ekso Bionics Expands Partnership with Kindred Healthcare Long-Term Acute Care Hospitals

5/6/21

Scribe Therapeutics wins Best New Technology Solution – Drug Development MedTech Breakthrough Award

5/4/21

4D Molecular Therapeutics Announces Collaboration on Leading Machine Learning Technology and Expertise from U.C. Berkeley to Expand Therapeutic Vector Evolution Platform

4/26/21

Health Canada Authorizes Lucira COVID-19 Test For Self-Testing At Home

4/21/21

US Para-Equestrian Trains in SuitX Medical Exoskeleton

4/21/21

To Design Truly Compostable Plastic, Scientists Take Cues From Nature

4/12/21

The 'Iron Man' Body Armor Many of us May Soon be Wearing

3/31/21

Lygos Achieves Commercial-Scale Production Capabilities for High-Quality Cannabinoids

3/31/21

Scribe Therapeutics Closes Series B Round With $100M To Target Gene Editing

3/30/21

Ambi Robotics, Formerly Ambidextrous, Raises $6.1M for Picking Robots

BEGIN Berkeley Gateway to Innovation
portal to the UC Berkeley entrepreneurship community

Join the IPIRA Mailing List

Read the IPIRA Newsletter

Follow @BerkeleyIPIRA

Accessibility | Nondiscrimination | Privacy

© 2022 Regents of the University of California. All Rights Reserved.